| Summary of Segment Loss Including Segment Expenses |
The table below is a summary of the segment loss, including significant segment expenses (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2026 |
|
|
2025 |
|
|
|
(in thousands) |
|
Operating expenses: |
|
|
|
|
|
|
Research, development, and laboratory |
|
$ |
10,058 |
|
|
$ |
12,092 |
|
Facility costs |
|
|
10,479 |
|
|
|
11,232 |
|
Support functions |
|
|
7,268 |
|
|
|
8,654 |
|
Stock-based compensation |
|
|
5,662 |
|
|
|
7,022 |
|
Technical operations and manufacturing |
|
|
3,986 |
|
|
|
7,436 |
|
Other(1) |
|
|
2,728 |
|
|
|
2,237 |
|
Research and development related success payments and contingent consideration |
|
|
8,433 |
|
|
|
1,957 |
|
Total operating expenses |
|
|
48,614 |
|
|
|
50,630 |
|
Loss from operations |
|
|
(48,614 |
) |
|
|
(50,630 |
) |
Interest income, net |
|
|
951 |
|
|
|
992 |
|
Other income, net |
|
|
453 |
|
|
|
249 |
|
Net loss |
|
$ |
(47,210 |
) |
|
$ |
(49,389 |
) |
(1) Other includes licensing costs, consulting fees, insurance, and business taxes for the three months ended March 31, 2026 and 2025.
|